Puma Biotechnology, Inc. ( PBYI) - Stock Earnings
PBYI Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | 8.8 million USD | 54.5 million USD |
| 2025Q4 | 13.4 million USD | 75.5 million USD |
| 2026Q1 | -3.8 million USD | 44.8 million USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
PBYI Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 21.6 million USD | 235.6 million USD |
| 2024 | 30.3 million USD | 230.5 million USD |
| 2025 | 31.1 million USD | 228.4 million USD |
| 2026 Est. | — | — |
PBYI
Price: $6.81
52 week price:
Earnings Per Share: 0.48 USD
P/E Ratio: 14.94
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 234700
Ebitda: -76.5 millionMarket Capitalization: 364.9 million